BioLife Solutions Inc reports results for the quarter ended December 31 - Earnings Summary

• BioLife Solutions Inc BLFS.OQ reported quarterly adjusted earnings of 26 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -30 cents. The mean expectation of ten analysts for the quarter was for a loss of 6 cents per share. Wall Street expected results to range from -10 cents to -3 cents per share.

• Revenue fell 30.6% to $22.71 million from a year ago; analysts expected $21.55 million.

• BioLife Solutions Inc's reported EPS for the quarter was 26 cents​.

• The company reported quarterly net income of $12.46 million.

• BioLife Solutions Inc shares had fallen by 7.6% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 26.2% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 10 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"

Wall Street's median 12-month price target for BioLife Solutions Inc is $31.00

This summary was machine generated from LSEG data March 3 at 03:25 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)